Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer
Crossref DOI link: https://doi.org/10.1007/s12282-015-0637-4
Published Online: 2015-09-09
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Noguchi, Shinzaburo
Kim, Hee Jeong
Jesena, Anita
Parmar, Vani
Sato, Nobuaki
Wang, Hwei-Chung
Lokejaroenlarb, Santi
Isidro, Jofel
Kim, Ku Sang
Itoh, Yohji
Shin, Eisei
Funding for this research was provided by:
AstraZeneca (NCT01073865)
License valid from 2015-09-09